|1.||Pelosi, Giuseppe: 8 articles (11/2015 - 02/2012)|
|2.||Gottlieb, Alice B: 6 articles (06/2014 - 12/2004)|
|3.||Cavazza, Alberto: 5 articles (11/2015 - 02/2012)|
|4.||Papotti, Mauro: 5 articles (11/2015 - 02/2012)|
|5.||Pastorino, Ugo: 5 articles (11/2015 - 02/2012)|
|6.||Rossi, Giulio: 5 articles (11/2015 - 02/2012)|
|7.||Tagawa, Masatoshi: 5 articles (03/2008 - 07/2003)|
|8.||Illei, Peter B: 4 articles (01/2016 - 05/2014)|
|9.||Garassino, Marina: 4 articles (11/2015 - 06/2013)|
|10.||Maisonneuve, Patrick: 4 articles (11/2015 - 02/2012)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
12/01/2004 - "The potential therapeutic activity of a human monoclonal antibody to the human interleukin-12 p40 subunit (anti-IL-12p40) has been established both in vitro and in vivo, warranting a first-in-human investigation in psoriasis. "
12/01/2004 - "A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis."
04/01/2015 - "To investigate the association of three common functional gene polymorphisms, namely TNF -308 G/A (rs1800629), IL12B (encoding the p40 subunit of IL-12/23) +1188 A/C (rs3212227), and IFNG +874 T/A (rs2430561) with psoriasis development and severity in Serbian patients. "
09/01/2011 - "TNF alpha and p40 blockade appear to be an effective biological treatment of severe lesional psoriasis. "
12/01/2007 - "IL-12 p40 antibody was well tolerated in a phase I clinical trial with few adverse events and substantial improvements in psoriasis in most individuals. "
11/01/2013 - "Preclinical model systems have predicted an important role of the p40 chain in intestinal inflammation. "
03/15/2011 - "In addition, C57BL/6 mice transgenic for the SJL/J 40 variant synthesized significantly more IL-12p70 upon LPS challenge and were more prone to develop colonic inflammation than did C57BL/6 mice transgenic for the C57BL/6-p40 variant. "
10/01/2003 - "In spite of the reduced clinical disease, the absence of p40 from the CNS has little impact on the degree of inflammation. "
09/01/2001 - "Furthermore, unlike vaccination with wild-type p40, vaccination of persistently infected symptomless B10.BR mice with p40(E130K,I136T) did not result in central nervous system inflammation and neurological disease. "
10/01/2014 - "Anti‑IL‑23p19 mAb was found to effectively attenuate colonic inflammation demonstrated by reduced DAI, CMDI and TDI scores, improvement in pathological evaluation and downregulation of expression levels of IL‑23p19, p40 (IL-23/12), ROR-γt and the downstream proinflammatory cytokine, IL-17. "
06/01/2011 - "The efficacy of p40 in three models of chemically induced colitis indicates tremendous therapeutic potential, though this finding will need to be verified in human patients."
06/01/2011 - "In the current study, we analyzed the mechanisms by which p40 regulates cellular responses in intestinal epithelial cells and p40's effects on experimental colitis using mouse models. "
10/18/2013 - "p40, a Lactobacillus rhamnosus GG (LGG)-derived soluble protein, ameliorates intestinal injury and colitis, reduces apoptosis, and preserves barrier function by transactivation of the EGF receptor (EGFR) in intestinal epithelial cells. "
01/01/2011 - "Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis."
07/18/2014 - "p40, a Lactobacillus rhamnosus GG-derived soluble protein, has been shown to transactivate the EGF receptor (EGFR) in intestinal epithelial cells, which is required for inhibition of apoptosis and preservation of barrier function in the colon, thereby ameliorating intestinal injury and colitis. "
01/01/2015 - "Significant upregulation or downregulation of gcIL-12 subunits, p35 and p40 by bacterial and viral infection confirms their potential role in anti-bacterial and anti-viral immune responses in fish. "
12/01/2010 - "Although attenuation of proinflammatory pathways may protect against tissue-damaging immunity early in life, this previously unrecognized p40 immune deficiency appears to result in considerably increased susceptibility to infection in human preterm newborns."
05/01/2009 - "Their expression profiles were studied by semi-quantitative RT-PCR in comparison with transcripts of the PI-1, Pin2 and PR1 gene families in various tissues, after wounding and Globodera rostochiensis infection of nematode-resistant genotypes P40 and LB7/4/c-I-7, and susceptible cv. "
12/01/2006 - "The rate of infection among patients with an American Society of Anesthesiologists (ASA) classification of 1 in the prophylaxis group was 7.3%, whereas among ASA 1 patients in a no-prophylaxis control group it was 10.3% (P=.40). "
03/01/2006 - "After infection, Tg mice displayed higher pulmonary p40 and p70 levels than wild type mice. "
01/01/2005 - "The inhibition of tumor growth in mice treated with Ad.p35 plus Ad.p40 and Ad.CD, followed by injection of 5-FC, was significantly greater than that in mice treated with Ad.CD/5-FC, a mixture of Ad.p35 plus Ad.p40, or Ad.GFP (control). "
03/02/1988 - "When analyses were conducted on which events not related to cancer recurrence were eliminated, the survival difference between the BCG and control groups became nonsignificant (P = .40); the cumulative odds at 5 years decreased from 1.28 to 1.10. "
01/01/2009 - "In the present study, we investigated whether forced expression of the p19-linked p40 gene in murine mammary cancer cells (MA891) produced antitumor effects in vivo. "
01/01/2016 - "These tumors are CK7, TTF-1, and napsin A positive and p40 negative. "
01/01/2016 - "Eleven tumors were CDX-2 positive (5 strong, 3 moderate, and 3 weak), all of which were also TTF-1 and napsin A positive and p40 negative. "
|1.||Interleukin-12 (IL 12)
|2.||Interleukin-23 (Interleukin 23)
|3.||monoclonal antibody CNTO 1275 (CNTO 1275)
|6.||Interleukin-17 (Interleukin 27)
|8.||Interleukin-10 (Interleukin 10)
|9.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|10.||Interleukin-6 (Interleukin 6)
|1.||Drug Therapy (Chemotherapy)
|3.||Activities of Daily Living (ADL)